Drug Insight: testosterone preparations-Reference-Cited by-同舟云学术

Drug Insight: testosterone preparations

Published:2006-12 Issue:12 Volume:3 Page:653-665
ISSN:1743-4270
Container-title:Nature Clinical Practice Urology
language:en
Short-container-title:Nat Rev Urol

Author:

Srinivas-Shankar Upendram,Wu Frederick CW

Publisher

Springer Science and Business Media LLC

Subject

Urology,General Medicine

Link

http://www.nature.com/articles/ncpuro0650.pdf

Reference80 articles.

1. Amory JK et al. (2005) Oral testosterone in oil plus dutasteride in men: a pharmacokinetic study. J Clin Endocrinol Metab 90: 2610–2617

2. Page ST et al. (2006) Oral nanomilled testosterone (T) plus dutasteride normalizes serum T in medically castrated men: a pharmacokinetic study. Presented at The Endocrine Society's 88th Annual Meeting (ENDO 2006) June 24–27, Boston, MA, USA

3. Zitzmann M et al. (2001) The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males. Clin Endocrinol (Oxf) 55: 649–657

4. Zitzmann M et al. (2001) The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity. J Clin Endocrinol Metab 86: 4867–4873

5. Gorczynska E et al. (1995) Androgens rapidly increase the cytosolic calcium concentration in Sertoli cells. Endocrinology 136: 2052–2059

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fabrication of silastic testosterone enanthate implants to achieve virilizing levels of serum testosterone in swine;MethodsX;2024-06

2. CYB561 supports the neuroendocrine phenotype in castration-resistant prostate cancer;PLOS ONE;2024-05-13

3. CYB561 supports the neuroendocrine phenotype in castration-resistant prostate cancer;2024-03-03

4. Protective effects of l-theanine and dihydromyricetin on reproductive function in male mice under heat stress;Food & Function;2024

5. Intramuscularly injected long-acting testosterone-cholesterol prodrug suspension with three different particle sizes: extended in vitro release and enhanced in vivo safety;Drug Delivery and Translational Research;2023-11-06